EUVIMEDEUVIMED entdecken
Crossref

Nebulized myo-Inositol increases oxygen saturation and relieves symptoms in patients with airways diseases

A. Spiga

International Journal of Medical Device and Adjuvant Treatments · 2021-09 · 4

DOI: 10.32113/ijmdat_20219_356 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Medical Device and Adjuvant Treatments, 2021-09. Verfasst von A. Spiga. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Recent findings have evidenced the beneficial activity of myo-Inositol (myo-Ins) for the treatment of airways diseases. The study was designed to examine its efficacy in counteracting respiratory diseases complications, using nebulization as delivery route. PATIENTS AND METHODS: 15 patients with different clinical features of airways diseases were treated for 15 days on average with nebulized myo-Ins. Peripheral capillary oxygen saturation (SpO2) levels and symptoms distribution were analyzed. RESULTS: All the patients experienced a significant increase in the SpO2 levels after the treatment with nebulized myo-Ins [98% (IQR 95-97.5) after the treatment vs. 96% (IQR 98-98) before the treatment] (p

Schlagwörter

myo-inositolnebulizationrespiratory diseasesspo2respiratory symptoms

Zitieren

APA

Spiga, A. (2021). Nebulized myo-Inositol increases oxygen saturation and relieves symptoms in patients with airways diseases. International Journal of Medical Device and Adjuvant Treatments, 4. https://doi.org/10.32113/ijmdat_20219_356

Vancouver

Spiga A. Nebulized myo-Inositol increases oxygen saturation and relieves symptoms in patients with airways diseases. International Journal of Medical Device and Adjuvant Treatments. 2021;4. doi:10.32113/ijmdat_20219_356

BibTeX
@article{Spiga2021,
  author = {Spiga, A.},
  title = {Nebulized myo-Inositol increases oxygen saturation and relieves symptoms in patients with airways diseases},
  journal = {International Journal of Medical Device and Adjuvant Treatments},
  year = {2021},
  volume = {4},
  doi = {10.32113/ijmdat_20219_356}
}
Kostenlos starten →